Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP930758.RAIh0NovXS-n7-u18VEG7MriPp2dYl_4S5POwEF14aDK4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP930758.RAIh0NovXS-n7-u18VEG7MriPp2dYl_4S5POwEF14aDK4130_assertion type Assertion NP930758.RAIh0NovXS-n7-u18VEG7MriPp2dYl_4S5POwEF14aDK4130_head.
- NP930758.RAIh0NovXS-n7-u18VEG7MriPp2dYl_4S5POwEF14aDK4130_assertion description "[Accordingly, we evaluated the predictive efficiency of qRT-PCR and immunohistochemical analysis (IHC) on excision cross complementation group 1 (ERCC1), breast cancer susceptibility gene 1 (BRCA1), ribonucleotide reductase subunit M1 (RRM1) and class III ?-tubulin (TUBB3).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP930758.RAIh0NovXS-n7-u18VEG7MriPp2dYl_4S5POwEF14aDK4130_provenance.
- NP930758.RAIh0NovXS-n7-u18VEG7MriPp2dYl_4S5POwEF14aDK4130_assertion evidence source_evidence_literature NP930758.RAIh0NovXS-n7-u18VEG7MriPp2dYl_4S5POwEF14aDK4130_provenance.
- NP930758.RAIh0NovXS-n7-u18VEG7MriPp2dYl_4S5POwEF14aDK4130_assertion SIO_000772 21996087 NP930758.RAIh0NovXS-n7-u18VEG7MriPp2dYl_4S5POwEF14aDK4130_provenance.
- NP930758.RAIh0NovXS-n7-u18VEG7MriPp2dYl_4S5POwEF14aDK4130_assertion wasDerivedFrom befree-2016 NP930758.RAIh0NovXS-n7-u18VEG7MriPp2dYl_4S5POwEF14aDK4130_provenance.
- NP930758.RAIh0NovXS-n7-u18VEG7MriPp2dYl_4S5POwEF14aDK4130_assertion wasGeneratedBy ECO_0000203 NP930758.RAIh0NovXS-n7-u18VEG7MriPp2dYl_4S5POwEF14aDK4130_provenance.